Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Treasury Shares (2016 - 2025)

Kiora Pharmaceuticals' Treasury Shares history spans 11 years, with the latest figure at $70985.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 52.01% year-over-year to $70985.0; the TTM value through Dec 2025 reached $70985.0, up 52.01%, while the annual FY2025 figure was $70985.0, 52.01% up from the prior year.
  • Treasury Shares reached $70985.0 in Q4 2025 per KPRX's latest filing, down from $7.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $13.1 million in Q2 2023 to a low of $24094.0 in Q2 2024.
  • Average Treasury Shares over 5 years is $3.6 million, with a median of $1.7 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: skyrocketed 5007.18% in 2021, then crashed 99.82% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $168932.0 in 2021, then soared by 884.19% to $1.7 million in 2022, then decreased by 12.69% to $1.5 million in 2023, then crashed by 96.78% to $46697.0 in 2024, then soared by 52.01% to $70985.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Treasury Shares are $70985.0 (Q4 2025), $7.0 million (Q3 2025), and $88432.0 (Q2 2025).